- creating solutions for tomorrow

R&D efforts are focused on developing vaccines that will meet the specific needs of different segments of the global population (e.g. development of the Meningococcal A Vaccine in collaboration with WHO and PATH for sub-Saharan Africa, development of Pandemic Influenza Vaccine) as well as on improving methods of vaccine delivery for its present range of vaccines viz. use of jet injectors, aerosol delivery, dry powder inhalation delivery etc. An example is the development of Aerosol Measles Vaccine which allows respiratory delivery of currently licensed Measles Vaccine, to make it a vaccine that is more safe, immunogenic, inexpensive, needle-free and easier to administer than an injection.

R&D initiatives also include development of better adjuvants, heat stable vaccines, conjugate vaccines, monoclonal antibodies and others. Besides, there is an extensive range of vaccines in the development pipeline undergoing various stages of testing and clinical evaluation.

Recognizing the global need of immunization for cost-effective vaccines against various infectious diseases, Serum Institute is actively associated with international agencies like WHO, PATH, NIBSC/HPA, Bill & Melinda Gates Foundation, CBER, AktivDry/Colorado University, EDQM, RIVM/NVI, NIH/CDC, Rhein Biotech, USAID, University of Massachusetts and several other international organizations. Serum Institute values the ethical principle to replace, reduce or refine animal testing and hence is actively involved in an effort to reduce animal suffering, and the development of possible alternatives to in vivo testing of its products.

Serum Institute has a team of highly qualified and motivated professionals consisting of scientists, pharmacists, chemists, microbiologists, immunologists along with a group of medical doctors, national and international consultants which form its core R&D group.

Serum Institute performs high quality pre-clinical and clinical research in compliance with GLP and GCP guidelines on all its products before they are marketed worldwide. After licensure, a diligent pharmacovigilance is maintained as per international norms.



Copyright © 2015 Serum Institute of India Limited. Legal Disclaimer.